|
Atomistry » Zinc » PDB 5gm3-5h7r » 5h4j | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Zinc » PDB 5gm3-5h7r » 5h4j » |
Zinc in PDB 5h4j: Crystal Structure of Human Dutpase in Complex with N-[(1R)-1-[3- (Cyclopentyloxy)-Phenyl]-Ethyl]-3-[(3,4-Dihydro-2,4-Dioxo-1(2H)- Pyrimidinyl)Methoxy]-1-PropanesulfonamideEnzymatic activity of Crystal Structure of Human Dutpase in Complex with N-[(1R)-1-[3- (Cyclopentyloxy)-Phenyl]-Ethyl]-3-[(3,4-Dihydro-2,4-Dioxo-1(2H)- Pyrimidinyl)Methoxy]-1-Propanesulfonamide
All present enzymatic activity of Crystal Structure of Human Dutpase in Complex with N-[(1R)-1-[3- (Cyclopentyloxy)-Phenyl]-Ethyl]-3-[(3,4-Dihydro-2,4-Dioxo-1(2H)- Pyrimidinyl)Methoxy]-1-Propanesulfonamide:
3.6.1.23; Protein crystallography data
The structure of Crystal Structure of Human Dutpase in Complex with N-[(1R)-1-[3- (Cyclopentyloxy)-Phenyl]-Ethyl]-3-[(3,4-Dihydro-2,4-Dioxo-1(2H)- Pyrimidinyl)Methoxy]-1-Propanesulfonamide, PDB code: 5h4j
was solved by
K.T.Chong,
S.Miyahara,
H.Miyakoshi,
M.Fukuoka,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Human Dutpase in Complex with N-[(1R)-1-[3- (Cyclopentyloxy)-Phenyl]-Ethyl]-3-[(3,4-Dihydro-2,4-Dioxo-1(2H)- Pyrimidinyl)Methoxy]-1-Propanesulfonamide
(pdb code 5h4j). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Crystal Structure of Human Dutpase in Complex with N-[(1R)-1-[3- (Cyclopentyloxy)-Phenyl]-Ethyl]-3-[(3,4-Dihydro-2,4-Dioxo-1(2H)- Pyrimidinyl)Methoxy]-1-Propanesulfonamide, PDB code: 5h4j: Zinc binding site 1 out of 1 in 5h4jGo back to![]() ![]()
Zinc binding site 1 out
of 1 in the Crystal Structure of Human Dutpase in Complex with N-[(1R)-1-[3- (Cyclopentyloxy)-Phenyl]-Ethyl]-3-[(3,4-Dihydro-2,4-Dioxo-1(2H)- Pyrimidinyl)Methoxy]-1-Propanesulfonamide
![]() Mono view ![]() Stereo pair view
Reference:
W.Yano,
T.Yokogawa,
T.Wakasa,
K.Yamamura,
A.Fujioka,
K.Yoshisue,
E.Matsushima,
S.Miyahara,
H.Miyakoshi,
J.Taguchi,
K.T.Chong,
Y.Takao,
M.Fukuoka,
K.Matsuo.
Tas-114, A First-in-Class Dual Dutpase/Dpd Inhibitor, Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-Based Chemotherapy. Mol. Cancer Ther. V. 17 1683 2018.
Page generated: Sun Oct 27 17:20:11 2024
ISSN: ESSN 1538-8514 PubMed: 29748212 DOI: 10.1158/1535-7163.MCT-17-0911 |
Last articlesFe in 2YXOFe in 2YRS Fe in 2YXC Fe in 2YNM Fe in 2YVJ Fe in 2YP1 Fe in 2YU2 Fe in 2YU1 Fe in 2YQB Fe in 2YOO |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |